Dr. John Kisiel, MD, Mayo Clinic, talks Sensitivity for BCLC for Stage A was 93%| Detect Hepatocellular Carcinoma Lesions in Future for DDW 2018.
Sensitivity for BCLC for Stage A was 93% | Detect Hepatocellular Carcinoma Lesions in Future
Advertisement
Sensitivity for BCLC for Stage A was 93% | Detect Hepatocellular Carcinoma Lesions in Future
By Editor